About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Biology in Patients With Reflux Esophagitis

NCT01194323·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Vanderbilt University Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male or female
Ages 18 years or older
Undergoing EGD as standard of care at Vanderbilt's Digestive Diseases Center
Esophageal erosion detected at EGD
Abnormal pH monitoring
Male or female
Ages 18 years or older
Undergoing EGD as standard of care at Vanderbilt's Digestive Diseases Center
No complaints or history o heartburn or acid regurgitation
No erosion at EGD
Normal pH monitoring

You may not be if

Less than 18 years of age
Unable to provide informed consent
Use of acid suppressive therapy within last 14 days
known history of Barrett's esophagus, gastric surgery, alcoholism, significant motility condition
contraindications to biopsy such as taking anticoagulants other than aspirin (coumadin, plavix) or allergies to local anesthetic

The record

StatusCompleted

PhaseNo phase

Taking part75

StartedNov 2010

UpdatedApr 4, 2017

Conditions

Where1

Vanderbilt University Digestive Diseases Center
Nashville, Tennessee, United States

Clareo Health | Biology in Patients With Reflux Esophagitis